Coming Soon
Learn about adrenal mass, also known as adrenal tumor or adrenal lesion, diagnosis. This resource provides information on healthcare best practices for clinical documentation and medical coding of adrenal masses, adrenal tumors, and adrenal lesions. Find guidance on appropriate ICD-10 and SNOMED CT codes for accurate reporting and billing related to adrenal mass diagnosis. Improve your medical documentation and coding accuracy with this comprehensive guide for adrenal lesions, tumors, and masses.
Also known as
Hyperaldosteronism
Overproduction of aldosterone by adrenal glands.
Benign neoplasm of adrenal gland
Non-cancerous tumor of the adrenal gland.
Malignant neoplasm of adrenal gland
Cancerous tumor of the adrenal gland.
Other specified endocrine disorders
Includes incidental adrenal masses or unspecified abnormalities.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the adrenal mass functional (hormone-producing)?
When to use each related code
| Description |
|---|
| Abnormal growth in adrenal gland. |
| Benign adrenal tumor. |
| Hormone-secreting adrenal tumor. |
Missing laterality (right, left, bilateral) for adrenal mass impacts accurate coding and reimbursement.
Unclear documentation of benign vs. malignant nature affects code selection and potential treatment.
If incidentally found, proper coding as incidentaloma vs. primary diagnosis requires specific documentation.
Q: What is the most effective imaging protocol for differentiating benign vs. malignant adrenal masses in asymptomatic patients?
A: While non-contrast CT is often the initial imaging modality for adrenal incidentalomas, differentiating benign from malignant adrenal masses requires further characterization. Contrast-enhanced CT with washout calculations can offer valuable information, though it's not always definitive. MRI can be helpful, particularly in characterizing lipid-rich adenomas. Chemical shift MRI can be especially useful for this purpose. Ultimately, the decision for further imaging or biopsy should be guided by factors like size, patient characteristics, and imaging features concerning for malignancy. Explore how S10.AI can enhance the interpretation of adrenal mass imaging and facilitate clinical decision-making.
Q: How do current guidelines recommend managing an incidentally discovered adrenal mass < 4cm with benign imaging characteristics in a hypertensive patient?
A: Current guidelines, including those from the American College of Radiology and the Endocrine Society, generally recommend hormonal evaluation (including assessment of aldosterone, cortisol, and metanephrines) for incidental adrenal masses, even in the absence of overt symptoms. For masses < 4cm with benign imaging features and no biochemical evidence of hormone hypersecretion, repeat imaging in 6-12 months is often recommended to ensure stability. However, in a hypertensive patient, careful assessment for primary aldosteronism is particularly important, as aldosterone-producing adenomas can contribute to hypertension. Consider implementing a standardized adrenal mass evaluation protocol within your practice to ensure consistent and evidence-based management. Learn more about how S10.AI can assist in developing customized diagnostic pathways for adrenal incidentalomas.
Patient presents with concerns regarding a potential adrenal mass, also known as an adrenal tumor or adrenal lesion. Presenting symptoms include (list specific symptoms e.g., abdominal pain, flank pain, hypertension, fatigue, weight changes, etc.). Physical examination findings include (document relevant findings e.g., palpable mass, abdominal tenderness, etc.). Differential diagnosis includes adrenal adenoma, adrenal carcinoma, pheochromocytoma, adrenal cyst, and myelolipoma. Imaging studies, including abdominal CT scan with contrast, adrenal protocol CT, and MRI abdomen, have been ordered to characterize the lesion and evaluate for size, location, and characteristics suggestive of malignancy. Laboratory tests, including serum cortisol, aldosterone, renin, and urinary metanephrines, are being conducted to assess adrenal function and screen for hormonal hypersecretion. The patient's medical history includes (list relevant medical history e.g., hypertension, diabetes, family history of endocrine disorders, etc.). The patient's surgical history includes (list relevant surgical history). Current medications include (list current medications). The patient has been informed about the potential need for adrenalectomy, either laparoscopic adrenalectomy or open adrenalectomy, depending on the final diagnosis and size of the mass. Further management will be determined based on imaging and laboratory results. Patient education provided on adrenal mass symptoms, adrenal cancer risk factors, adrenal incidentaloma management, and the importance of follow-up care. The patient will be scheduled for a follow-up appointment to discuss results and treatment options. ICD-10 codes (list relevant ICD-10 codes e.g., D35.0, D35.1, etc.) are being considered.